Discrepancies and overdiagnosis in breast cancer organized screening. A "methodology'' systematic review

被引:0
作者
Gocko, X. [1 ,2 ,3 ]
Leclerq, M. [1 ]
Plotton, C. [1 ]
机构
[1] Univ Jacques Lisfranc, Fac Med Gen St Etienne, Campus Sante Innovat,10 Rue Marandiere, F-42270 St Priest En Jarez, France
[2] EA4607, Lab SNA EPIS, F-42055 St Etienne 2, France
[3] EA7425, Hlth Serv & Performance Res HESPER, F-42055 St Etienne 2, France
来源
REVUE D EPIDEMIOLOGIE ET DE SANTE PUBLIQUE | 2018年 / 66卷 / 06期
关键词
Screening; Breast cancer; Overdiagnosis; Lead time; Carcinoma intraductal noninfiltrating; NATURAL-HISTORY; OVER-DIAGNOSIS; MAMMOGRAPHY; PROGRAM; TIME; TRIAL; SIMULATION; ADJUSTMENT; SERVICE;
D O I
10.1016/j.respe.2018.08.007
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background. - The risk-benefit ratio of breast cancer organized screening is the focus of much scientific controversy, especially about overdiagnosis. The aim of this study was to relate methodological discrepancies to variations in rates of overdiagnosis to help build future decision aids and to better communicate with patients. Methods. - A systematic review of methodology was conducted by two investigators who searched Medline and Cochrane databases from 01/01/2004 to 12/31/2016. Results were restricted to randomized controlled trials (RCTs) and observational studies in French or English that examined the question of the overdiagnosis computation. Results. - Twenty-three observational studies and four RCTs were analyzed. The methods used comparisons of annual or cumulative incidence rates (age-cohort model) in populations invited to screen versus non-invited populations. Lead time and ductal carcinoma in situ (DCIS) were often taken into account. Some studies used statistical modeling based on the natural history of breast cancer and gradual screening implementation. Adjustments for lead time lowered the rate of overdiagnosis. Rate discrepancies, ranging from 1 to 15 % for some authors and around 30 % for others, could be explained by the hypotheses accepted concerning very slow growing tumors or tumors that regress spontaneously. Conclusion. - Apparently, research has to be centered on the natural history of breast cancer in order to provide responses concerning the questions raised by the overdiagnosis controversy. (C) 2018 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:395 / 403
页数:9
相关论文
共 50 条
[31]   Prostate cancer screening: the problem of overdiagnosis and lessons to be learned from breast cancer screening [J].
Ciatto, S ;
Zappa, M ;
Bonardi, R ;
Gervasi, G .
EUROPEAN JOURNAL OF CANCER, 2000, 36 (11) :1347-1350
[32]   Tomosynthesis as a screening tool for breast cancer: A systematic review [J].
Coop, P. ;
Cowling, C. ;
Lawson, C. .
RADIOGRAPHY, 2016, 22 (03) :E190-E195
[33]   Global guidelines for breast cancer screening: A systematic review* [J].
Ren, Wenhui ;
Chen, Mingyang ;
Qiao, Youlin ;
Zhao, Fanghui .
BREAST, 2022, 64 :85-99
[34]   Benefits and harms of breast cancer screening: Cohort study of breast cancer mortality and overdiagnosis [J].
Wang, Sabrina ;
Sultana, Farhana ;
Kavanagh, Anne ;
Nickson, Carolyn ;
Karahalios, Amalia ;
Gurrin, Lyle C. ;
English, Dallas R. .
CANCER MEDICINE, 2023, 12 (17) :18120-18132
[35]   Anticipatory anxiety and participation in cancer screening. A systematic review [J].
Goodwin, Belinda ;
Anderson, Laura ;
Collins, Katelyn ;
Sanjida, Saira ;
Riba, Marcos ;
Singh, Gursharan K. ;
Campbell, Kimberley M. ;
Green, Heather ;
Ishaque, Sana ;
Kwok, Alastair ;
Opozda, Melissa J. ;
Pearn, Amy ;
Shaw, Joanne ;
Sansom-Daly, Ursula M. ;
Tsirgiotis, Joanna M. ;
Janda, Monika ;
Grech, Lisa .
PSYCHO-ONCOLOGY, 2023, 32 (12) :1773-1786
[36]   Information around organized breast cancer screening. Do INCa and Cancer Rose meet criteria for decision aids? [J].
Gocko, X. ;
Fondacci, M. ;
Dibi, C. ;
Plotton, C. .
REVUE D EPIDEMIOLOGIE ET DE SANTE PUBLIQUE, 2020, 68 (01) :33-36
[37]   The distribution of ductal carcinoma in situ (DCIS) grade in 4232 women and its impact on overdiagnosis in breast cancer screening [J].
van Luijt, P. A. ;
Heijnsdijk, E. A. M. ;
Fracheboud, J. ;
Overbeek, L. I. H. ;
Broeders, M. J. M. ;
Wesseling, J. ;
den Heeten, G. J. ;
de Koning, H. J. .
BREAST CANCER RESEARCH, 2016, 18
[38]   The effect of mammography pain on repeat participation in breast cancer screening: A systematic review [J].
Whelehan, Patsy ;
Evans, Andy ;
Wells, Mary ;
MacGillivray, Steve .
BREAST, 2013, 22 (04) :389-394
[39]   Overdiagnosis due to breast cancer screening: updated estimates of the Helsinki service study in Finland [J].
Heinavaara, S. ;
Sarkeala, T. ;
Anttila, A. .
BRITISH JOURNAL OF CANCER, 2014, 111 (07) :1463-1468
[40]   Factors Influencing Overuse of Breast Cancer Screening: A Systematic Review [J].
Sharma, Ritu ;
Pannikottu, Jean ;
Xu, Yunwen ;
Tung, Monica ;
Nothelle, Stephanie ;
Oakes, Allison H. ;
Segal, Jodi B. .
JOURNAL OF WOMENS HEALTH, 2018, 27 (09) :1142-1151